Loading…

High plasma levels of COL10A1 are associated with advanced tumor stage in gastric cancer patients

Gastric cancer (GC) remains an aggressive malignancy with a high rate of mortality, being the third leading cause of cancer-related death. More than one million newly diagnosed cases and 782685 deaths due to GC were reported in 2018. GC is characterized by limited effective treatment options and the...

Full description

Saved in:
Bibliographic Details
Published in:World journal of gastroenterology : WJG 2020-06, Vol.26 (22), p.3024-3033
Main Authors: Necula, Laura, Matei, Lilia, Dragu, Denisa, Pitica, Ioana, Neagu, Ana Iulia, Bleotu, Coralia, Dima, Simona, Popescu, Irinel, Diaconu, Carmen C, Chivu-Economescu, Mihaela
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c396t-502d4b5eb52d6998ae657bcef6b6118ba4c288d12c5a3bb9d618c1a2f9fdf59c3
cites cdi_FETCH-LOGICAL-c396t-502d4b5eb52d6998ae657bcef6b6118ba4c288d12c5a3bb9d618c1a2f9fdf59c3
container_end_page 3033
container_issue 22
container_start_page 3024
container_title World journal of gastroenterology : WJG
container_volume 26
creator Necula, Laura
Matei, Lilia
Dragu, Denisa
Pitica, Ioana
Neagu, Ana Iulia
Bleotu, Coralia
Dima, Simona
Popescu, Irinel
Diaconu, Carmen C
Chivu-Economescu, Mihaela
description Gastric cancer (GC) remains an aggressive malignancy with a high rate of mortality, being the third leading cause of cancer-related death. More than one million newly diagnosed cases and 782685 deaths due to GC were reported in 2018. GC is characterized by limited effective treatment options and the lack of consistent biomarkers for the diagnosis and prognosis of these patients. The discovery of new biomarkers useful in the early diagnosis of GC is mandatory. To evaluate the potential of COL10A1 as a circulating biomarker for the diagnosis and prognosis of gastric adenocarcinoma patients. Plasma and tissue obtained from 49 patients with gastric adenocarcinoma have been used in exploring the expression of COL10A1. Real-time PCR and western blot techniques were used to evaluate COL10A1 level in gastric tumor tissue compared to normal adjacent tissue. The circulating level of COL10A1 was also evaluated by ELISA in plasma of gastric adenocarcinoma patients. Survival analysis was made in order to evaluate the potential of COL10A1 as a biomarker for the diagnosis and prognosis of gastric adenocarcinoma patients. Our results showed a significant increase in COL10A1 gene expression and protein levels in gastric tumor tissue compared to adjacent normal tissue ( < 0.05). COL10A1 seems to show an elevated expression from the beginning of carcinogenesis, in the early stages, and its increased level remains elevated during cancer progression. A significant increase of COL10A1 plasma level in gastric adenocarcinoma patients was also identified. Moreover, increased COL10A1 plasma level was associated with poor survival of the patients. Plasma COL10A1 performed a diagnostic value in GC with area under the receiver operating characteristic curve (AUC) of 0.9171 ( = 0.0002), sensitivity of 87.76%, and specificity of 100.0%. Furthermore, this study demonstrated the potential role of plasma COL10A1 in the early detection of GC, as in the early stage, we obtained an AUC of 0.8789 ( = 0.0030), sensitivity of 81.25%, and specificity of 100.0%. Circulating expression level of COL10A1 is significantly increased in gastric adenocarcinoma patients being associated with poor survival and is a potential biomarker for early detection of GC.
doi_str_mv 10.3748/wjg.v26.i22.3024
format article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7304107</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>32587446</sourcerecordid><originalsourceid>FETCH-LOGICAL-c396t-502d4b5eb52d6998ae657bcef6b6118ba4c288d12c5a3bb9d618c1a2f9fdf59c3</originalsourceid><addsrcrecordid>eNpVkEtLw0AUhQdRbK3uXcn8gcR5ZTLZCKWoFQrd6Hq4mUzSKXkxk6b4702piq4ul8N3DnwI3VMS81Sox-O-ikcmY8dYzAkTF2jOGM0ipgS5RHNKSBplnKUzdBPCnhDGecKu0YyzRKVCyDmCtat2uK8hNIBrO9o64K7Eq-2GkiXF4C2GEDrjYLAFPrphh6EYoTXTNxyazuMwQGWxa3EFYfDOYHNKPe5hcLYdwi26KqEO9u77LtDHy_P7ah1ttq9vq-UmMjyTQ5QQVog8sXnCCpllCqxM0tzYUuaSUpWDMEypgjKTAM_zrJBUGQqszMqiTDLDF-jp3Nsf8sYWZtr2UOveuwb8p-7A6f9J63a66kadciIoSacCci4wvgvB2_KXpUSfdOtJt55060m3PumekIe_m7_Aj1_-BXAGfxY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>High plasma levels of COL10A1 are associated with advanced tumor stage in gastric cancer patients</title><source>PubMed Central</source><creator>Necula, Laura ; Matei, Lilia ; Dragu, Denisa ; Pitica, Ioana ; Neagu, Ana Iulia ; Bleotu, Coralia ; Dima, Simona ; Popescu, Irinel ; Diaconu, Carmen C ; Chivu-Economescu, Mihaela</creator><creatorcontrib>Necula, Laura ; Matei, Lilia ; Dragu, Denisa ; Pitica, Ioana ; Neagu, Ana Iulia ; Bleotu, Coralia ; Dima, Simona ; Popescu, Irinel ; Diaconu, Carmen C ; Chivu-Economescu, Mihaela</creatorcontrib><description>Gastric cancer (GC) remains an aggressive malignancy with a high rate of mortality, being the third leading cause of cancer-related death. More than one million newly diagnosed cases and 782685 deaths due to GC were reported in 2018. GC is characterized by limited effective treatment options and the lack of consistent biomarkers for the diagnosis and prognosis of these patients. The discovery of new biomarkers useful in the early diagnosis of GC is mandatory. To evaluate the potential of COL10A1 as a circulating biomarker for the diagnosis and prognosis of gastric adenocarcinoma patients. Plasma and tissue obtained from 49 patients with gastric adenocarcinoma have been used in exploring the expression of COL10A1. Real-time PCR and western blot techniques were used to evaluate COL10A1 level in gastric tumor tissue compared to normal adjacent tissue. The circulating level of COL10A1 was also evaluated by ELISA in plasma of gastric adenocarcinoma patients. Survival analysis was made in order to evaluate the potential of COL10A1 as a biomarker for the diagnosis and prognosis of gastric adenocarcinoma patients. Our results showed a significant increase in COL10A1 gene expression and protein levels in gastric tumor tissue compared to adjacent normal tissue ( &lt; 0.05). COL10A1 seems to show an elevated expression from the beginning of carcinogenesis, in the early stages, and its increased level remains elevated during cancer progression. A significant increase of COL10A1 plasma level in gastric adenocarcinoma patients was also identified. Moreover, increased COL10A1 plasma level was associated with poor survival of the patients. Plasma COL10A1 performed a diagnostic value in GC with area under the receiver operating characteristic curve (AUC) of 0.9171 ( = 0.0002), sensitivity of 87.76%, and specificity of 100.0%. Furthermore, this study demonstrated the potential role of plasma COL10A1 in the early detection of GC, as in the early stage, we obtained an AUC of 0.8789 ( = 0.0030), sensitivity of 81.25%, and specificity of 100.0%. Circulating expression level of COL10A1 is significantly increased in gastric adenocarcinoma patients being associated with poor survival and is a potential biomarker for early detection of GC.</description><identifier>ISSN: 1007-9327</identifier><identifier>EISSN: 2219-2840</identifier><identifier>DOI: 10.3748/wjg.v26.i22.3024</identifier><identifier>PMID: 32587446</identifier><language>eng</language><publisher>United States: Baishideng Publishing Group Inc</publisher><subject>Adenocarcinoma - genetics ; Basic Study ; Biomarkers, Tumor - genetics ; Early Detection of Cancer ; Humans ; Prognosis ; Stomach Neoplasms - genetics</subject><ispartof>World journal of gastroenterology : WJG, 2020-06, Vol.26 (22), p.3024-3033</ispartof><rights>The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.</rights><rights>The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. 2020</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c396t-502d4b5eb52d6998ae657bcef6b6118ba4c288d12c5a3bb9d618c1a2f9fdf59c3</citedby><cites>FETCH-LOGICAL-c396t-502d4b5eb52d6998ae657bcef6b6118ba4c288d12c5a3bb9d618c1a2f9fdf59c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7304107/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7304107/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27922,27923,53789,53791</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32587446$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Necula, Laura</creatorcontrib><creatorcontrib>Matei, Lilia</creatorcontrib><creatorcontrib>Dragu, Denisa</creatorcontrib><creatorcontrib>Pitica, Ioana</creatorcontrib><creatorcontrib>Neagu, Ana Iulia</creatorcontrib><creatorcontrib>Bleotu, Coralia</creatorcontrib><creatorcontrib>Dima, Simona</creatorcontrib><creatorcontrib>Popescu, Irinel</creatorcontrib><creatorcontrib>Diaconu, Carmen C</creatorcontrib><creatorcontrib>Chivu-Economescu, Mihaela</creatorcontrib><title>High plasma levels of COL10A1 are associated with advanced tumor stage in gastric cancer patients</title><title>World journal of gastroenterology : WJG</title><addtitle>World J Gastroenterol</addtitle><description>Gastric cancer (GC) remains an aggressive malignancy with a high rate of mortality, being the third leading cause of cancer-related death. More than one million newly diagnosed cases and 782685 deaths due to GC were reported in 2018. GC is characterized by limited effective treatment options and the lack of consistent biomarkers for the diagnosis and prognosis of these patients. The discovery of new biomarkers useful in the early diagnosis of GC is mandatory. To evaluate the potential of COL10A1 as a circulating biomarker for the diagnosis and prognosis of gastric adenocarcinoma patients. Plasma and tissue obtained from 49 patients with gastric adenocarcinoma have been used in exploring the expression of COL10A1. Real-time PCR and western blot techniques were used to evaluate COL10A1 level in gastric tumor tissue compared to normal adjacent tissue. The circulating level of COL10A1 was also evaluated by ELISA in plasma of gastric adenocarcinoma patients. Survival analysis was made in order to evaluate the potential of COL10A1 as a biomarker for the diagnosis and prognosis of gastric adenocarcinoma patients. Our results showed a significant increase in COL10A1 gene expression and protein levels in gastric tumor tissue compared to adjacent normal tissue ( &lt; 0.05). COL10A1 seems to show an elevated expression from the beginning of carcinogenesis, in the early stages, and its increased level remains elevated during cancer progression. A significant increase of COL10A1 plasma level in gastric adenocarcinoma patients was also identified. Moreover, increased COL10A1 plasma level was associated with poor survival of the patients. Plasma COL10A1 performed a diagnostic value in GC with area under the receiver operating characteristic curve (AUC) of 0.9171 ( = 0.0002), sensitivity of 87.76%, and specificity of 100.0%. Furthermore, this study demonstrated the potential role of plasma COL10A1 in the early detection of GC, as in the early stage, we obtained an AUC of 0.8789 ( = 0.0030), sensitivity of 81.25%, and specificity of 100.0%. Circulating expression level of COL10A1 is significantly increased in gastric adenocarcinoma patients being associated with poor survival and is a potential biomarker for early detection of GC.</description><subject>Adenocarcinoma - genetics</subject><subject>Basic Study</subject><subject>Biomarkers, Tumor - genetics</subject><subject>Early Detection of Cancer</subject><subject>Humans</subject><subject>Prognosis</subject><subject>Stomach Neoplasms - genetics</subject><issn>1007-9327</issn><issn>2219-2840</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNpVkEtLw0AUhQdRbK3uXcn8gcR5ZTLZCKWoFQrd6Hq4mUzSKXkxk6b4702piq4ul8N3DnwI3VMS81Sox-O-ikcmY8dYzAkTF2jOGM0ipgS5RHNKSBplnKUzdBPCnhDGecKu0YyzRKVCyDmCtat2uK8hNIBrO9o64K7Eq-2GkiXF4C2GEDrjYLAFPrphh6EYoTXTNxyazuMwQGWxa3EFYfDOYHNKPe5hcLYdwi26KqEO9u77LtDHy_P7ah1ttq9vq-UmMjyTQ5QQVog8sXnCCpllCqxM0tzYUuaSUpWDMEypgjKTAM_zrJBUGQqszMqiTDLDF-jp3Nsf8sYWZtr2UOveuwb8p-7A6f9J63a66kadciIoSacCci4wvgvB2_KXpUSfdOtJt55060m3PumekIe_m7_Aj1_-BXAGfxY</recordid><startdate>20200614</startdate><enddate>20200614</enddate><creator>Necula, Laura</creator><creator>Matei, Lilia</creator><creator>Dragu, Denisa</creator><creator>Pitica, Ioana</creator><creator>Neagu, Ana Iulia</creator><creator>Bleotu, Coralia</creator><creator>Dima, Simona</creator><creator>Popescu, Irinel</creator><creator>Diaconu, Carmen C</creator><creator>Chivu-Economescu, Mihaela</creator><general>Baishideng Publishing Group Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20200614</creationdate><title>High plasma levels of COL10A1 are associated with advanced tumor stage in gastric cancer patients</title><author>Necula, Laura ; Matei, Lilia ; Dragu, Denisa ; Pitica, Ioana ; Neagu, Ana Iulia ; Bleotu, Coralia ; Dima, Simona ; Popescu, Irinel ; Diaconu, Carmen C ; Chivu-Economescu, Mihaela</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c396t-502d4b5eb52d6998ae657bcef6b6118ba4c288d12c5a3bb9d618c1a2f9fdf59c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adenocarcinoma - genetics</topic><topic>Basic Study</topic><topic>Biomarkers, Tumor - genetics</topic><topic>Early Detection of Cancer</topic><topic>Humans</topic><topic>Prognosis</topic><topic>Stomach Neoplasms - genetics</topic><toplevel>online_resources</toplevel><creatorcontrib>Necula, Laura</creatorcontrib><creatorcontrib>Matei, Lilia</creatorcontrib><creatorcontrib>Dragu, Denisa</creatorcontrib><creatorcontrib>Pitica, Ioana</creatorcontrib><creatorcontrib>Neagu, Ana Iulia</creatorcontrib><creatorcontrib>Bleotu, Coralia</creatorcontrib><creatorcontrib>Dima, Simona</creatorcontrib><creatorcontrib>Popescu, Irinel</creatorcontrib><creatorcontrib>Diaconu, Carmen C</creatorcontrib><creatorcontrib>Chivu-Economescu, Mihaela</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>World journal of gastroenterology : WJG</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Necula, Laura</au><au>Matei, Lilia</au><au>Dragu, Denisa</au><au>Pitica, Ioana</au><au>Neagu, Ana Iulia</au><au>Bleotu, Coralia</au><au>Dima, Simona</au><au>Popescu, Irinel</au><au>Diaconu, Carmen C</au><au>Chivu-Economescu, Mihaela</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>High plasma levels of COL10A1 are associated with advanced tumor stage in gastric cancer patients</atitle><jtitle>World journal of gastroenterology : WJG</jtitle><addtitle>World J Gastroenterol</addtitle><date>2020-06-14</date><risdate>2020</risdate><volume>26</volume><issue>22</issue><spage>3024</spage><epage>3033</epage><pages>3024-3033</pages><issn>1007-9327</issn><eissn>2219-2840</eissn><abstract>Gastric cancer (GC) remains an aggressive malignancy with a high rate of mortality, being the third leading cause of cancer-related death. More than one million newly diagnosed cases and 782685 deaths due to GC were reported in 2018. GC is characterized by limited effective treatment options and the lack of consistent biomarkers for the diagnosis and prognosis of these patients. The discovery of new biomarkers useful in the early diagnosis of GC is mandatory. To evaluate the potential of COL10A1 as a circulating biomarker for the diagnosis and prognosis of gastric adenocarcinoma patients. Plasma and tissue obtained from 49 patients with gastric adenocarcinoma have been used in exploring the expression of COL10A1. Real-time PCR and western blot techniques were used to evaluate COL10A1 level in gastric tumor tissue compared to normal adjacent tissue. The circulating level of COL10A1 was also evaluated by ELISA in plasma of gastric adenocarcinoma patients. Survival analysis was made in order to evaluate the potential of COL10A1 as a biomarker for the diagnosis and prognosis of gastric adenocarcinoma patients. Our results showed a significant increase in COL10A1 gene expression and protein levels in gastric tumor tissue compared to adjacent normal tissue ( &lt; 0.05). COL10A1 seems to show an elevated expression from the beginning of carcinogenesis, in the early stages, and its increased level remains elevated during cancer progression. A significant increase of COL10A1 plasma level in gastric adenocarcinoma patients was also identified. Moreover, increased COL10A1 plasma level was associated with poor survival of the patients. Plasma COL10A1 performed a diagnostic value in GC with area under the receiver operating characteristic curve (AUC) of 0.9171 ( = 0.0002), sensitivity of 87.76%, and specificity of 100.0%. Furthermore, this study demonstrated the potential role of plasma COL10A1 in the early detection of GC, as in the early stage, we obtained an AUC of 0.8789 ( = 0.0030), sensitivity of 81.25%, and specificity of 100.0%. Circulating expression level of COL10A1 is significantly increased in gastric adenocarcinoma patients being associated with poor survival and is a potential biomarker for early detection of GC.</abstract><cop>United States</cop><pub>Baishideng Publishing Group Inc</pub><pmid>32587446</pmid><doi>10.3748/wjg.v26.i22.3024</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1007-9327
ispartof World journal of gastroenterology : WJG, 2020-06, Vol.26 (22), p.3024-3033
issn 1007-9327
2219-2840
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7304107
source PubMed Central
subjects Adenocarcinoma - genetics
Basic Study
Biomarkers, Tumor - genetics
Early Detection of Cancer
Humans
Prognosis
Stomach Neoplasms - genetics
title High plasma levels of COL10A1 are associated with advanced tumor stage in gastric cancer patients
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T23%3A24%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=High%20plasma%20levels%20of%20COL10A1%20are%20associated%20with%20advanced%20tumor%20stage%20in%20gastric%20cancer%20patients&rft.jtitle=World%20journal%20of%20gastroenterology%20:%20WJG&rft.au=Necula,%20Laura&rft.date=2020-06-14&rft.volume=26&rft.issue=22&rft.spage=3024&rft.epage=3033&rft.pages=3024-3033&rft.issn=1007-9327&rft.eissn=2219-2840&rft_id=info:doi/10.3748/wjg.v26.i22.3024&rft_dat=%3Cpubmed_cross%3E32587446%3C/pubmed_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c396t-502d4b5eb52d6998ae657bcef6b6118ba4c288d12c5a3bb9d618c1a2f9fdf59c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/32587446&rfr_iscdi=true